AACR Annual Meeting 2026

⭐️ Excellent #AACR26 abstract breakdown of 🔑 abstracts for #CommunityOncology by the @OncBrothers

As technology races ahead, we appreciated the expertise of @ValsamoA from @hopkinskimmel as she presented her thoughts on the clinical va...

The need for high levels of #ctDNA to increase assay sensitivity and reduce false negatives continues to be a challenge in the field. Add...

During #AACR26, researchers from MSK presented on innovative therapeutic advances — including clinical trials showing promise for people ...

#AACR26 highlights #CommunityOnc:

New therapeutic strategies were spotlighted at #AACR26, with first-time presentations of the structures and mechanisms behind four novel ...

"China Dinner", held in conjunction with #AACR26, successfully concluded in San Diego! eChinaHealth, together with CACA, USCACA, and part...

A Disturbance in the Force

Major Symposium on mechanobiology: tumour-associated fibrosis stiffens the stroma, creating tension that promotes tumorigenesis and suppresses antitumour immunity. Chair Valerie M. Weaver (UCSF) reported stiffer breast tissue in BRCA carriers and in high-density breast tissue; Dennis E. Discher (Penn) and Christina Curtis (Stanford) also presented.

Dr. Robot? AI Agents in the Clinic

Advances in Technology session on agentic AI for clinical decision support. Dorin Comaniciu (Siemens Healthineers) described specialised agents analysing multi-source imaging to feed treatment planning. Tae Hyun Hwang (Vanderbilt) demonstrated multi-agent live imaging of drug dynamics in individual tumours.

Dr. Rob Jenq, director of City of Hope's microbiome program, shares science-backed nutrition recommendations that support a healthier mic...

Thanks for following along at #AACR26! Reach out to Sophia Kisling, PhD, Assistant Editor, at sophia.kisling@aacr.org with questions, and...

During her Presidential Address at #AACR26, Lillian L. Siu explored how discovery in the molecular landscape of head and neck cancer coul...

Not ready to leave 🏙️🌴🫰🏻

That is a wrap! Thank you @AACR for another great Annual Meeting. We enjoyed connecting with colleagues and the warm San Diego weather. W...

We thank the more than 23,000 people who participated in the AACR Annual Meeting 2026 in person and online. #AACR26 received more than 19...

Combining ramucirumab with pembrolizumab did not improve OS vs SOC for patients with previously treated stage IV or recurrent NSCLC.

@CancerTodayMag @AACR This tracks with what we see clinically. Traditional West African diets — rich in legumes, leafy greens, and fiber ...

Eating a plant-forward diet during adolescence is associated with a lower risk for an aggressive subtype of breast cancer, according to r...

#AACR26

The closing plenary is over, and so is #AACR26. We thank Program Chairs Paul Mischel and Alice Shaw and the entire Program Committee for ...

Congratulations to Jose Colina, Analisa DiFeo, and colleagues on their simultaneous publication—Ciliated Cells Drive Critical STING-Media...

ZW191 highlights!

#AACR26 highlighted the power of collaboration to drive meaningful progress in cancer research.

@shameel_shafqat @MayoCancerCare Congratulations on your presentation at #AACR26! #CancerResearchSavesLives®

We had a fun time at the AACR Runners for Research 5K in San Diego last weekend. It was a great event for an even greater cause! Over $25...

From single-cell to multiomics, the future of cancer research is evolving fast.

Our Dr. Ecaterina Dumbrava gave a summary of clinical research and clinical trials presented at #AACR26. She noted a number of common the...

That's a wrap on #AACR26! We had a great time in San Diego with clients and partners, and meeting fellow industry professionals. Learn mo...

Wrapping up with Ecaterina Dumbrava ( @UTMDAnderson ) highlighting clinical trials presented at #AACR26 https://t.co/UMB4CoRF6U

A sincere thank you to @AACR faculty and staff for an amazing #AACR26 ! 👏👏👏